TREACE MEDICAL CONCEPTS, INC. (TMCI) › Shareholders' EquityTREACE MEDICAL CONCEPTS, INC. (TMCI) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: $5.95M2019: $3.16M2020: $776.0K2021: $93.07M2022: $60.53M2023: $137.94M2024: $112.89M2025: $87.33M$87.33M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$87.33M-22.6%2024$112.89M-18.2%2023$137.94M+127.9%2022$60.53M-35.0%2021$93.07M+11893.9%2020$776.0K-75.5%2019$3.16M-46.9%2018$5.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share